At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 94 enrolled
Drug / intervention
ReNu MultiPlus® MultiPurpose Solution +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
In Brief
A Phase 4 clinical trial evaluating ReNu MultiPlus® MultiPurpose Solution, OPTI-FREE® RepleniSH®, and 1 other intervention for Myopia and Refractive Error. Completed, enrolled 94 participants across 2 sites.
Detailed Summary
The purpose of this study is to utilize in-vivo confocal microscopy to describe differences in corneal epithelial immune status across three lens care regimens in new contact lens wearers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Refractive Error
CountriesUnited States
CollaboratorsUniversity of Iowa, Alcon Research
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedDec 2010
Primary CompletionFeb 2012
Study CompletionJul 2012
TodayJul 2026
First PostedDec 1, 2010
Enrollment StartAug 1, 2010
Primary CompletionFeb 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 15.6 years ago
Interventions
ReNu MultiPlus® MultiPurpose Solutiondrug
Contact lens care regimen
OPTI-FREE® RepleniSH®drug
Contact Lens care regimen
Clear Care®drug
Contact lens care regimen